Status:

COMPLETED

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Lead Sponsor:

University of Vermont

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Food and Drug Administration (FDA)

Conditions:

Tobacco Use Disorder

Eligibility:

FEMALE

21-44 years

Phase:

NA

Brief Summary

Despite marked reductions in cigarette smoking in the general population, smoking among economically disadvantaged women has increased. Smoking among women of reproductive age is a particular concern ...

Eligibility Criteria

Inclusion

  • Female
  • 21 to 44 years old

Exclusion

  • Male
  • Under 21 years old
  • Over 44 years old

Key Trial Info

Start Date :

October 18 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 27 2023

Estimated Enrollment :

326 Patients enrolled

Trial Details

Trial ID

NCT04092387

Start Date

October 18 2020

End Date

November 27 2023

Last Update

March 18 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Johns Hopkins University

Baltimore, Maryland, United States, 21287

2

University of Vermont

Burlington, Vermont, United States, 05401